Facebook Twitter

St. Louis’ Jones Pharma agrees to merge with King

SHARE St. Louis’ Jones Pharma agrees to merge with King

ST. LOUIS (AP) — Jones Pharma Inc. of St. Louis has agreed to be bought by King Pharmaceutical Inc. of Bristol, Tenn., in a deal initially valued at up to $3.4 billion.

Shareholders of both companies will get a chance to vote on the deal this year. The companies hope to close the deal by the end of the third quarter.